Skip to main content
Terug
Watch Compare

Adicet Bio, Inc.

Datakwaliteit: 83%
ACET
Nasdaq Manufacturing Chemicals
€ 6,90
▲ € 0,35 (5,34%)
Marktkapitalisatie: 66,24 M
Prijs
€ 6,90
Marktkapitalisatie
66,24 M
Dagbereik
€ 6,51 — € 6,97
52-Weeksbereik
€ 6,01 — € 17,44
Volume
181.601
Openen € 6,55
50D / 200D Gem.
€ 7,26
4,90% below
50D / 200D Gem.
€ 10,11
31,75% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -96,98 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-96,33%
Onder sectorgemiddelde (-51,02%)
ROIC-72,15%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio5,62
Interest Coverage-3392,06

Waardering

PE (TTM)
-0,57
Boven sectorgemiddelde (-1,98)
P/B Ratio0,61
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -0,6 -2,0
P/B 0,6 5,1
ROE % -96,3 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -116,80 M
ROE -96,33% ROA -76,98%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -96,98 M
ROIC -72,15% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5,62
Interest Coverage -3392,06 Asset Turnover N/A
Working Capital 87,55 M Tangible Book Value 109,14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,57 Forward P/E N/A
P/B Ratio 0,61 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -146,41%
Market Cap 66,24 M Enterprise Value 37,14 M
Per Share
EPS (Diluted TTM) -16,95 Revenue / Share N/A
FCF / Share -10,10 OCF / Share -9,92
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83,03%
SBC-Adj. FCF -112,38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -116,80 M -117,12 M -142,66 M -69,79 M -62,00 M
EPS (Diluted) -16,95 -1,33 -3,31 -1,70 —
Gross Profit — — — — —
Operating Income -122,11 M -127,62 M -152,04 M -72,55 M -61,43 M
EBITDA — — — — —
R&D Expenses 99,13 M 99,32 M 106,04 M 71,25 M 48,94 M
SG&A Expenses — — — — —
D&A 6,38 M 6,47 M 6,10 M 2,58 M 1,54 M
Interest Expense 36.000,0 4.000,0 25.000,0 80.000,0 176.000,0
Income Tax 0,0 0,0 0,0 0,0 -125.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 192,36 M 220,22 M 207,30 M 330,69 M 338,94 M
Total Liabilities 33,15 M 33,61 M 37,12 M 38,35 M 35,81 M
Shareholders' Equity 159,21 M 186,61 M 170,18 M 292,34 M 303,13 M
Total Debt — — — — —
Cash & Equivalents 38,92 M 56,50 M 159,71 M 257,66 M 277,54 M
Current Assets 160,93 M 180,14 M 162,27 M 261,04 M 282,44 M
Current Liabilities 21,53 M 19,39 M 19,29 M 19,71 M 16,32 M